“…However, the apparent Ca 2+ sensitivity of TMEM16F is lower than that of TMEM16A and TMEM16B. Differing from CaCCs that are readily activated by elevated cytosolic Ca 2+ from either cell surface Ca 2+ channels or from internal stores ( Yang et al, 2012 ; Cabrita et al, 2017 ; Genovese et al, 2019 ; Jin et al, 2013 ; Shah et al, 2020 ; Zhang et al, 2017 ; Takayama et al, 2014 ), TMEM16F activation requires more robust and sustained intracellular Ca 2+ elevation ( Suzuki et al, 2010 ; Le et al, 2021 ; Yu et al, 2015 ; Yang et al, 2012 ; Grubb et al, 2013 ; Liang and Yang, 2021 ; Shimizu et al, 2013 ; Ye et al, 2018 ; Ye et al, 2019 ). Ca 2+ ionophores are widely used to artificially trigger TMEM16F activation and these pharmacological tools allow us to study the biophysical properties or functional expression of TMEM16F in native cells ( Suzuki et al, 2010 ; Le et al, 2019 ; Yu et al, 2015 ; Zhang et al, 2020 ).…”